Calamos Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,014
| Closed | -$235K | – | 313 |
|
2024
Q2 | $235K | Buy |
1,014
+13
| +1% | +$3.01K | 0.01% | 263 |
|
2024
Q1 | $216K | Hold |
1,001
| – | – | 0.01% | 274 |
|
2023
Q4 | $259K | Hold |
1,001
| – | – | 0.02% | 260 |
|
2023
Q3 | $257K | Hold |
1,001
| – | – | 0.02% | 273 |
|
2023
Q2 | $285K | Buy |
1,001
+1
| +0.1% | +$285 | 0.02% | 263 |
|
2023
Q1 | $278K | Hold |
1,000
| – | – | 0.02% | 262 |
|
2022
Q4 | $277K | Hold |
1,000
| – | – | 0.02% | 264 |
|
2022
Q3 | $267K | Sell |
1,000
-17
| -2% | -$4.54K | 0.02% | 257 |
|
2022
Q2 | $207K | Sell |
1,017
-42
| -4% | -$8.55K | 0.02% | 300 |
|
2022
Q1 | $223K | Buy |
1,059
+42
| +4% | +$8.84K | 0.02% | 312 |
|
2021
Q4 | $244K | Buy |
+1,017
| New | +$244K | 0.02% | 301 |
|
2016
Q4 | – | Sell |
-2,277
| Closed | -$713K | – | 224 |
|
2016
Q3 | $713K | Sell |
2,277
-207
| -8% | -$64.8K | 0.12% | 163 |
|
2016
Q2 | $601K | Sell |
2,484
-186
| -7% | -$45K | 0.11% | 166 |
|
2016
Q1 | $695K | Sell |
2,670
-26
| -1% | -$6.77K | 0.13% | 169 |
|
2015
Q4 | $826K | Sell |
2,696
-896
| -25% | -$275K | 0.16% | 165 |
|
2015
Q3 | $1.05M | Sell |
3,592
-4,085
| -53% | -$1.19M | 0.25% | 133 |
|
2015
Q2 | $3.1M | Buy |
7,677
+1,937
| +34% | +$782K | 0.73% | 38 |
|
2015
Q1 | $2.42M | Buy |
5,740
+3,504
| +157% | +$1.48M | 0.61% | 51 |
|
2014
Q4 | $759K | Sell |
2,236
-39
| -2% | -$13.2K | 0.22% | 152 |
|
2014
Q3 | $753K | Buy |
2,275
+10
| +0.4% | +$3.31K | 0.22% | 149 |
|
2014
Q2 | $714K | Buy |
2,265
+40
| +2% | +$12.6K | 0.2% | 160 |
|
2014
Q1 | $681K | Buy |
2,225
+163
| +8% | +$49.9K | 0.2% | 158 |
|
2013
Q4 | $577K | Sell |
2,062
-50
| -2% | -$14K | 0.18% | 168 |
|
2013
Q3 | $508K | Buy |
2,112
+89
| +4% | +$21.4K | 0.17% | 168 |
|
2013
Q2 | $435K | Buy |
+2,023
| New | +$435K | 0.15% | 165 |
|